Add BrightSurf on Google Email

Science News for August 30, 2026


KAIST opens the era of industrial-scale microbial foods, proposing growth strategies for the next-generation protein market

KAIST researchers analyzed key challenges in microbial food industry and proposed growth strategies for next-generation protein market. The study emphasizes the importance of manufacturing readiness, market entry strategies, and regulatory compliance in commercializing microbial foods.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalOne Earth·DateAug 30, 2026

Tailored exercise program shown to reduce atrial fibrillation burden

A one-year tailored exercise program significantly reduced atrial fibrillation (AF) burden and improved cardiorespiratory fitness in patients with non-permanent AF. Despite lack of significant improvements in quality of life, the exercise intervention showed meaningful benefits in measures of fitness and hospitalisations.

SourceEuropean Society of Cardiology·DateAug 30, 2026
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Gene silencer therapy in transthyretin amyloid cardiomyopathy

Researchers found that gene silencer therapy may be beneficial for patients with transthyretin amyloid cardiomyopathy, with attenuated benefits observed when combined with TTR stabilizer therapy. The study will be presented at the European Society of Cardiology Congress in Munich, Germany.

SourceJAMA Network·JournalJAMA·DateAug 30, 2026

Long-term intensive blood-pressure control reduces dementia risk

A community-based trial in rural China found that intensive blood-pressure lowering intervention reduced dementia risk by 15% compared to usual care. The intervention also showed benefits in cognitive impairment and serious adverse events. This scalable approach may help reduce the increasing burden of dementia globally.

SourceEuropean Society of Cardiology·DateAug 30, 2026
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Cardiologist referrals improve cholesterol levels in prostate cancer patients, but may not be necessary for all: study

A large international study found that routine referrals to cardiologists or internists improved cholesterol levels in prostate cancer patients, but did not lead to fewer heart attacks, strokes, or cardiovascular deaths. Researchers noted that fewer participants experienced these complications than expected, making it harder to determi...

SourceMcMaster University·JournalJAMA Internal Medicine·DateAug 30, 2026

A TAVI-first strategy was noninferior to a PCI-first strategy in patients with severe aortic stenosis and concomitant coronary artery disease

A new study finds that a TAVI-first strategy is noninferior to a PCI-first strategy in patients with severe aortic stenosis and concomitant coronary artery disease. The trial showed that fewer patients in the TAVI-first group ultimately underwent PCI, and life-threatening bleeding occurred at a lower rate with the TAVI-first strategy.

SourceEuropean Society of Cardiology·DateAug 30, 2026

New research shows transcatheter repair reduces death and heart failure hospitalisation in severe tricuspid regurgitation vs. medical therapy alone

Transcatheter tricuspid valve repair improved heart failure hospitalization and all-cause mortality in patients with severe tricuspid regurgitation. The TRIC-I-HF trial demonstrated a significant benefit in reducing hard clinical outcomes, including quality-of-life improvements and sustained reductions in mortality.

SourceEuropean Society of Cardiology·DateAug 30, 2026
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Novel drug shows promise in an early phase trial in heart failure

A phase IIb trial found that AZD5462, an oral relaxin agonist, improved cardiac function in patients with heart failure, particularly at the lowest dose, with no safety concerns noted. The study suggests that AZD5462 may be a promising addition to existing therapies for heart failure.

SourceEuropean Society of Cardiology·DateAug 30, 2026
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.